Literature DB >> 19127207

Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome.

Céline Bailly-Botuha1, Virginie Colomb, Elizabeth Thioulouse, Marie-Clotilde Berthe, Karine Garcette, Béatrice Dubern, Olivier Goulet, Rémy Couderc, Jean-Philippe Girardet.   

Abstract

Plasma citrulline was recently shown to reflect the residual functional enterocyte mass in various situations characterized by intestinal failure. However, few data are available in children with short bowel syndrome. The objective of this study was to assess the value of citrulline assays in this situation. Prospective plasma citrulline assays were performed in 31 children with short bowel syndrome. Median age was 16 mo (range, 1 mo to 15 y), and median follow-up was 14 mo (6-40 mo). The energy supplied by parenteral nutrition (PN), served to assess intestinal failure severity. Plasma citrulline at inclusion showed a positive correlation with residual short bowel length. Subsequent values correlated negatively with intestinal failure severity. Plasma citrulline increased over time during or after weaning from PN (from 15.8 +/- 11.5 microM to 19.3 +/- 3.8 microM) but remained stable and low in patients who continued to need PN (6.5 +/- 3.0 microM at inclusion and 7.7 +/- 6.0 microM at last follow-up). No weaned patients had a residual short bowel length less than 40 cm and plasma citrulline less than 11 microM. Our findings constitute the first evidence that serial plasma citrulline assays help to monitor residual small bowel adaptation in children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19127207     DOI: 10.1203/PDR.0b013e31819986da

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  13 in total

1.  Plasma citrulline as marker of bowel adaptation in children with short bowel syndrome.

Authors:  Antonella Diamanti; Fabio Panetta; Paolo Gandullia; Francesco Morini; Cristian Noto; Giuliano Torre; Antonella Lezo; Bianca Goffredo; Antonella Daniele; Manuela Gambarara
Journal:  Langenbecks Arch Surg       Date:  2011-06-01       Impact factor: 3.445

2.  Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn's disease: preliminary report.

Authors:  Antonella Diamanti; Daniela Knafelz; Fabio Panetta; Fiammetta Bracci; Manuela Gambarara; Bronislava Papadatou; Antonella Daniele; Bianca M Goffredo; Simona Pezzi; Giuliano Torre
Journal:  Int J Colorectal Dis       Date:  2011-06-14       Impact factor: 2.571

Review 3.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

Review 4.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

5.  Use of serum citrulline concentrations from routine newborn screen as a biomarker for necrotizing enterocolitis.

Authors:  Sharmila Babu; Malavika Prasad; Malki Miller; Mark Morrissey; Alok Bhutada; Mary Rojas; Shantanu Rastogi
Journal:  Pediatr Surg Int       Date:  2019-03-09       Impact factor: 1.827

Review 6.  Short bowel syndrome in children: current and potential therapies.

Authors:  Victor Uko; Kadakkal Radhakrishnan; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

7.  Clinical characteristics associated with postoperative intestinal epithelial barrier dysfunction in children with congenital heart disease.

Authors:  Katri V Typpo; Claire B Larmonier; Jendar Deschenes; Daniel Redford; Pawel R Kiela; Fayez K Ghishan
Journal:  Pediatr Crit Care Med       Date:  2015-01       Impact factor: 3.624

Review 8.  Nutrition: A Primary Therapy in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Bryan Wilson; Katri Typpo
Journal:  Front Pediatr       Date:  2016-10-13       Impact factor: 3.418

9.  Determining optimal therapy of dogs with chronic enteropathy by measurement of serum citrulline.

Authors:  Magda Gerou-Ferriani; Rhiannon Allen; Peter-John M Noble; Alexander J German; Marco Caldin; Daniel J Batchelor
Journal:  J Vet Intern Med       Date:  2018-04-16       Impact factor: 3.333

10.  Apo AIV and Citrulline Plasma Concentrations in Short Bowel Syndrome Patients: The Influence of Short Bowel Anatomy.

Authors:  M Dolores López-Tejero; Núria Virgili; Jordi Targarona; Jorge Ruiz; Natalia García; Denise Oró; Judit García-Villoria; Gloria Creus; Ana M Pita
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.